Dapagliflozin 5 mg and Vildagliptin 100 mg Tablets

DAPA VILDA 5/100 SR is a clinically advanced oral antidiabetic medication formulated for the effective management of type 2 diabetes mellitus in adults. Each tablet contains a fixed-dose combination of Dapagliflozin (5 mg) and Vildagliptin SR (100 mg), two well-established agents that work through complementary mechanisms to optimize glycemic control and reduce long-term diabetes-related complications.

This dual-action therapy is designed to:

• Eliminate excess glucose from the body through the kidneys (Dapagliflozin).
  
  

• Enhance insulin secretion and suppress glucagon release for better glucose regulation (Vildagliptin SR).
  
  

Together, these actions help patients achieve sustained blood sugar control, while also supporting cardiovascular and renal health.

How Does DAPA VILDA 5/100 SR Work?

• Dapagliflozin (SGLT2 inhibitor): Prevents glucose reabsorption in the kidneys, promoting its excretion via urine and thereby lowering blood sugar levels.
  
  

• Vildagliptin (DPP-4 inhibitor, sustained-release): Increases incretin hormone activity, leading to higher insulin secretion from pancreatic beta cells and reduced glucose production from the liver.
  
  

This combination offers a balanced and long-lasting glycemic effect, making it a reliable treatment option for type 2 diabetes.

Uses of DAPA VILDA 5/100 SR

• Effective management of type 2 diabetes mellitus.
  
  

• Helps in achieving stable glycemic control when lifestyle modifications and monotherapy are insufficient.
  
  

• Supports cardiovascular and renal protection through better glucose and weight regulation.
  
  

• Reduces the risk of complications such as nephropathy, neuropathy, and cardiovascular events.
  
  

Key Benefits

Dual mechanism of action for improved blood sugar control.
Sustained-release formulation ensures prolonged therapeutic effects.
Supports weight management and cardiovascular health.
Complements diet, exercise, and other antidiabetic therapies.

Possible Side Effects

Like all medications, DAPA VILDA 5/100 SR may cause some side effects. Most are mild and manageable, but serious reactions can occur in rare cases.

Common side effects:

• Increased urination
  
  

• Genital or urinary tract infections
  
  

• Headache, dizziness
  
  

• Nausea, mild stomach upset
  
  

• Low blood sugar (especially with insulin or sulfonylureas)
  
  

Rare but serious side effects:

• Signs of ketoacidosis (nausea, vomiting, abdominal pain, rapid breathing)
  
  

• Pancreatitis or elevated liver enzymes
  
  

• Severe allergic reactions (rash, swelling, difficulty breathing)
  
  

Precautions Before Use

• Kidney function: Regular monitoring is essential, as dapagliflozin affects renal function.
  
  

• Liver health: Vildagliptin may influence liver enzymesperiodic testing is recommended.
  
  

• Hydration: Maintain proper fluid intake to minimize dehydration risk.
  
  

• Pregnancy & breastfeeding: Use only under medical supervision, as safety is not fully established.
  
  

• Inform your doctor if you have a history of UTIs, cardiovascular disease, or hypersensitivity.
  
  

Drug Interactions

DAPA VILDA 5/100 SR may interact with certain medications:

• Other antidiabetic drugs (insulin, sulfonylureas): May increase hypoglycemia risk.
  
  

• Diuretics: Can worsen dehydration and electrolyte imbalance.
  
  

• Nephrotoxic drugs: May alter dapagliflozin effectiveness.
  
  

• Liver-metabolized drugs: Vildagliptin may affect metabolism and enzyme activity.
  
  

Always inform your healthcare provider about all medications and supplements you are taking.

Conclusion

DAPA VILDA 5/100 SR represents a modern, dual-action solution for type 2 diabetes management. By combining the benefits of dapagliflozin and vildagliptin in a sustained-release formulation, it delivers superior blood sugar control, supports long-term cardiovascular and renal health, and reduces the risk of diabetes-related complications.

When used alongside a healthy diet, regular physical activity, and medical supervision, DAPA VILDA 5/100 SR can help patients achieve lasting improvements in their diabetes management and overall quality of life.